Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice.
Abdel-Mageed
Aly S
AS
Senagore
Anthony J
AJ
Pietryga
Daniel W
DW
Connors
Robert H
RH
Giambernardi
Troy A
TA
Hay
Rick V
RV
Deng
Weiwen
W
D000818:Animals; D005260:Female; D005720:Gamma Rays / Q000009:adverse effects*; D005818:Genetic Engineering; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000201:enzymology*; D051379:Mice; D008807:Mice, Inbred BALB C; D039902:Multipotent Stem Cells / Q000201:enzymology*; D011833:Radiation Injuries, Experimental / Q000201:enzymology / Q000235:genetics / Q000628:therapy*; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism*; D014916:Whole-Body Irradiation
D013482:Superoxide Dismutase